Til Stürmer

Til Stürmer

Auto-generated profile, based on publicly available information

Til Stürmer

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2015 in Current Epidemiology Reports
Verified
Journal Article
Closed access
PDF file
JLJennifer L. Lund
Jennifer L. Lund
DRDavid B Richardson
David B Richardson
TSTil Stürmer
Til Stürmer

1 May 2006 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
TSTil Stürmer
Til Stürmer
MJManisha Joshi
Manisha Joshi
RGRobert J. Glynn
Robert J. Glynn
JAJerry Avorn
Jerry Avorn
KRKenneth J. Rothman
Kenneth J. Rothman
SSSebastian Schneeweiss
Sebastian Schneeweiss

17 August 2010 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
TSTil Stürmer
Til Stürmer
KRKenneth J. Rothman
Kenneth J. Rothman
JAJerry Avorn
Jerry Avorn
RGRobert J. Glynn
Robert J. Glynn
Frailty, a poorly measured confounder in older patients, can promote treatment in some situations and discourage it in others. This can create unmeasured confounding and lead to nonuniform treatment effects over the propensity score (PS). The authors compared bias and mean squared error for various PS implementations under PS trimming, thereby excluding persons treated contrary to prediction. Cohort studies were simulated with a binary treatment T as a function of 8 covariates X. Two of the covariates were assumed to be unmeasured strong risk factors for the outcome and present in persons treated contrary to prediction. The outcome Y was simulated as a Poisson function of T and all X’s. In analyses based on measured covariates only, the range of PS's was trimmed asymmetrically according to the percentile of PS in treated patients at the lower end and in untreated patients at the upper end. PS trimming reduced bias due to unmeasured confounders and mean squared error in most scenarios assessed. Treatment effect estimates based on PS range restrictions do not correspond to a causal parameter but may be less biased by such unmeasured confounding. Increasing validity based on PS trimming may be a unique advantage of PS's over conventional outcome models.

13 February 2014 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
TST. Stürmer
T. Stürmer
RWR. Wyss
R. Wyss
RGR. J. Glynn
R. J. Glynn
MBM. A. Brookhart
M. A. Brookhart
Treatment effects, especially when comparing two or more therapeutic alternatives as in comparative effectiveness research, are likely to be heterogeneous across age, gender, co‐morbidities and co‐medications. Propensity scores (PSs), an alternative to multivariable outcome models to control for measured confounding, have specific advantages in the presence of heterogeneous treatment effects. Implementing PSs using matching or weighting allows us to estimate different overall treatment effects in differently defined populations. Heterogeneous treatment effects can also be due to unmeasured confounding concentrated in those treated contrary to prediction. Sensitivity analyses based on PSs can help to assess such unmeasured confounding. PSs should be considered a primary or secondary analytic strategy in nonexperimental medical research, including pharmacoepidemiology and nonexperimental comparative effectiveness research.

27 January 2022 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
RSRachel Sendor
Rachel Sendor
TSTil Stürmer
Til Stürmer

1 August 2005 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
TSTil Stürmer
Til Stürmer
SSSebastian Schneeweiss
Sebastian Schneeweiss
JAJerry Avorn
Jerry Avorn
RGRobert J. Glynn
Robert J. Glynn
Often, data on important confounders are not available in cohort studies. Sensitivity analyses based on the relation of single, but not multiple, unmeasured confounders with an exposure of interest in a separate validation study have been proposed. In this paper, the authors controlled for measured confounding in the main cohort using propensity scores (PS's) and addressed unmeasured confounding by estimating two additional PS's in a validation study. The “error-prone” PS exclusively used information available in the main cohort. The “gold standard” PS additionally included data on covariates available only in the validation study. Based on these two PS's in the validation study, regression calibration was applied to adjust regression coefficients. This propensity score calibration (PSC) adjusts for unmeasured confounding in cohort studies with validation data under certain, usually untestable, assumptions. The authors used PSC to assess the relation between nonsteroidal antiinflammatory drugs (NSAIDs) and 1-year mortality in a large cohort of elderly persons. “Traditional” adjustment resulted in a hazard ratio for NSAID users of 0.80 (95% confidence interval (CI): 0.77, 0.83) as compared with an unadjusted hazard ratio of 0.68 (95% CI: 0.66, 0.71). Application of PSC resulted in a more plausible hazard ratio of 1.06 (95% CI: 1.00, 1.12). Until the validity and limitations of PSC have been assessed in different settings, the method should be seen as a sensitivity analysis.